Booth Bruce bought KYMR
June 17, 2026 · Form 4 insider transaction
Booth Bruce bought 11,741 shares of Kymera Therapeutics, Inc. at $20.00 per share, a transaction worth $234.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,741
Price
$20.00
Total value
$234.8K
InsiderBooth Bruce
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after11,741
OwnershipDirect
10b5-1 planNo
AmendedNo